NMTC

Novogradac Conference to Address New Markets Tax Credit Financing Challenges, Solutions in 2024 and Beyond

Retrieved on: 
Thursday, December 21, 2023

SAN FRANCISCO, Dec. 21, 2023 /PRNewswire-PRWeb/ -- Community development professionals will discuss navigating higher-than-normal inflation and interest rates and overcoming tax credit financing challenges at the Novogradac 24th Annual New Markets Tax Credit Conference, to be held Jan. 25-26, 2024, at the Omni La Costa Resort & Spa in Carlsbad, California. Conference panelists will also discuss the legislative future of the new markets tax credit (NMTC), allocation award insights from Community Development Financial Institutions (CDFI) Fund professionals and other hot topics in the NMTC community.

Key Points: 
  • Novogradac to Host 24th Annual New Markets Tax Credit Conference Jan. 25-26, 2024
    SAN FRANCISCO, Dec. 21, 2023 /PRNewswire-PRWeb/ -- Community development professionals will discuss navigating higher-than-normal inflation and interest rates and overcoming tax credit financing challenges at the Novogradac 24th Annual New Markets Tax Credit Conference , to be held Jan. 25-26, 2024, at the Omni La Costa Resort & Spa in Carlsbad, California.
  • Conference panelists will also discuss the legislative future of the new markets tax credit (NMTC), allocation award insights from Community Development Financial Institutions (CDFI) Fund professionals and other hot topics in the NMTC community.
  • Other sessions on the agenda include panels on leveraging the NMTC, investing in diversity and helping qualified active low-income community businesses address financing challenges.
  • In addition to the panel topics, Novogradac will host two pre-conference workshops on Jan. 24, 2024.

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe

Retrieved on: 
Thursday, November 16, 2023

EDEN PRAIRIE, Minn., Nov. 16, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that, the United States Patent and Trademark Office (“USPTO”) issued a Notice of Allowance for U.S. Patent Application 16/812,702, titled “Agent-Delivering Neural Probe Devices and Related Systems and Methods,” which covers novel electrodes that can operate as a standard neural electrode that also delivers a treatment agent to a target area of the patient’s brain.

Key Points: 
  • A Notice of Allowance is issued by the USPTO after examination of a patent application and a determination that a patent should be granted from the application.
  • NeuroOne anticipates the issuance of the patent in the coming months.
  • Dave Rosa, CEO of NeuroOne, commented, “The Company continues to strengthen its existing patent portfolio with this recent notification by the USPTO.
  • These allowances are especially important as we advance our efforts to partner with existing biopharma companies to offer the next combination device that can provide both drug delivery and sEEG recording capabilities.”

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Tuesday, November 14, 2023

EDEN PRAIRIE, Minn., Nov. 14, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that it has appointed medtech executive Christopher R. Volker as Chief Operating Officer.

Key Points: 
  • Mr. Volker joins NeuroOne from Abbott Laboratories which acquired Cardiovascular Systems, Inc. in April 2023.
  • He began his career in healthcare and technology investment banking where he gained expertise in M&A, strategic planning, asset sales, and growth equity investments.
  • The equity award was approved in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement of awards that are not made under a stockholder approved equity plan.
  • The option award has an exercise price of $1.32 per share, the closing price of NeuroOne’s common stock on November 10, 2023, the date of the grant.

Broadstreet Names Chris Rakers to Lead Fast-growing Fund Administration Business

Retrieved on: 
Tuesday, December 12, 2023

Broadstreet Impact Services has named a seasoned fund solutions executive to lead its fund administration team as part of a multi-year strategy to continue the firm’s significant growth.

Key Points: 
  • Broadstreet Impact Services has named a seasoned fund solutions executive to lead its fund administration team as part of a multi-year strategy to continue the firm’s significant growth.
  • This week, Chris Rakers joined Broadstreet as managing director of fund administration following almost two decades leading tech-enabled fund operations for alternative investment managers.
  • He also served in various roles at Custom House Fund Services, including as chief operating officer, leading a global fund administration team across the US, Europe, and Asia.
  • “We are excited to add Chris’ remarkable range of fund administration experience to our existing impact investing expertise,” said Kevin Boes, CEO of Broadstreet.

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System

Retrieved on: 
Tuesday, November 7, 2023

EDEN PRAIRIE, Minn., Nov. 07, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that it has responded to the Food and Drug Administration’s (FDA) questions regarding the Company’s previous submission of a 510(k) for its OneRF™ Ablation System. The Company expects to receive additional communication back from the FDA in thirty days or less.

Key Points: 
  • The Company expects to receive additional communication back from the FDA in thirty days or less.
  • The OneRF system uses the already implanted sEEG electrodes to record brain activity and allow for ablation of nervous tissue when connected to the Company’s proprietary radio frequency (RF) generator.
  • If cleared by the FDA, NeuroOne’s OneRF 510(k) submission represents the first step in bringing to market an innovative RF ablation system in the field of neurology and neurosurgery.
  • The system utilizes a customized RF generator with real-time temperature monitoring capabilities, allowing clinicians to have greater control over temperature management during the ablation.

MycoWorks' Ribbon-Cutting Ceremony Celebrates its Next-Gen Material Fine Mycelium™ Production Facility in South Carolina

Retrieved on: 
Wednesday, October 25, 2023

UNION, S.C., Oct. 25, 2023 /PRNewswire/ -- MycoWorks celebrated the opening and start of production at its first full-scale Fine Mycelium™ facility in Union, S.C., with a ribbon-cutting attended by South Carolina Governor Henry McMaster, as well as other government officials, community leaders, brand partners, and supporters. The world-class manufacturing plant gives MycoWorks the capacity to scale-up to meet demand for their luxury leather-like material Reishi™. Produced with the company's patented technology for partners including Hermès and Ligne Roset, MycoWorks' new plant has already made a significant impact by spurring new investment in Union's storefronts, housing, and employment portfolio.

Key Points: 
  • The world-class manufacturing plant gives MycoWorks the capacity to scale-up to meet demand for their luxury leather-like material Reishi™.
  • South Carolina Governor Henry McMaster delivered impactful remarks on MycoWorks' arrival in the state.
  • "I was proud to join with MycoWorks to celebrate the grand opening of their new Union facility," said Governor Henry McMaster .
  • Our partnerships with the Upstate educational ecosystem and the leadership in South Carolina will enable us to bring continued training and high quality jobs."

Enhanced Community Development Awarded $40 Million in New Markets Tax Credit Allocation from U.S. Treasury Department

Retrieved on: 
Tuesday, October 17, 2023

NEW YORK, Oct. 17, 2023 /PRNewswire/ -- Enhanced Community Development, a subsidiary of Enhanced Capital, announced that it has been awarded $40 million in New Markets Tax Credits (NMTC) allocation.

Key Points: 
  • NEW YORK, Oct. 17, 2023 /PRNewswire/ -- Enhanced Community Development, a subsidiary of Enhanced Capital, announced that it has been awarded $40 million in New Markets Tax Credits (NMTC) allocation.
  • This award marks the ninth time Enhanced Community Development has received a federal NMTC allocation, resulting in a cumulative total of $430 million in federal NMTC allocation since 2006.
  • The U.S. Treasury Department's Community Development Financial Institutions (CDFI) Fund announced the allocation to Enhanced Capital as part of a $5 billion award to 102 Community Development Entities (CDEs) in the 2022 round of the NMTC Program.
  • "Enhanced Community Development's New Markets Tax Credit award amplifies our mission of stimulating jobs and growth in small businesses and providing community services in economically underserved urban and rural areas," highlighted Catherine Blume, Vice President at Enhanced Capital.

NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023

Retrieved on: 
Friday, October 13, 2023

EDEN PRAIRIE, Minn., Oct. 13, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that CFO Ron McClurg will present at the ThinkEquity Conference in New York on Thursday, October 19, 2023.

Key Points: 
  • EDEN PRAIRIE, Minn., Oct. 13, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that CFO Ron McClurg will present at the ThinkEquity Conference in New York on Thursday, October 19, 2023.

Truist receives $65 million New Markets Tax Credit allocation to support communities across the U.S.

Retrieved on: 
Friday, October 13, 2023

As part of the program, Truist provides loans and investments with reduced interest rates and/or non-traditional terms and conditions to support community development projects.

Key Points: 
  • As part of the program, Truist provides loans and investments with reduced interest rates and/or non-traditional terms and conditions to support community development projects.
  • "Truist has been active in the NMTC Program for many years and we're proud to have been trusted with more than $750 million in allocation authority, to date," said Jamise Goodman, NMTC program director for Truist Community Development Enterprises.
  • Through its investments in community development projects, Truist Community Capital works to ensure access to services and amenities that directly benefit neighborhoods and residents.
  • "This new round of allocation will build on the impactful investments Truist is making to enhance neighborhoods, support residents and improve access to vital services."

U.S. Bank Receives $55 Million in New Markets Tax Credit Allocation

Retrieved on: 
Friday, September 29, 2023

U.S. Bancorp Impact Finance, a subsidiary of U.S. Bank, and its community development entity (CDE) – USBCDE, LLC – received $55 million of New Markets Tax Credit (NMTC) allocation from the U.S. Department of Treasury.

Key Points: 
  • U.S. Bancorp Impact Finance, a subsidiary of U.S. Bank, and its community development entity (CDE) – USBCDE, LLC – received $55 million of New Markets Tax Credit (NMTC) allocation from the U.S. Department of Treasury.
  • The allocation is part of the federal government’s $5 billion NMTC program, which helps economically distressed communities attract private investment capital.
  • USBCDE, LLC has now been awarded more than $1 billion in total allocations, one of only three CDEs to do so.
  • It is one of 102 CDEs to receive a share of the NMTC allocation authority package announced by the Treasury’s Community Development Financial Institutions Fund (CDFI Fund).